ArticleTherapeutics and clinical risk management2017

Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes.

Guntram Schernthaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.